Lavipharm S.A. (ATH:LAVI)

Lavipharm Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	164	134	134	64	30	24
Market Cap Growth	32.29%	0.36%	107.29%	117.58%	23.40%	113.64%
Enterprise Value	192	157	161	98	66	62
Last Close Price	0.97	0.78	0.78	0.37	1.58	1.28
PE Ratio	79.81	14.93	71.42	77.29	17.20	11.47
PS Ratio	2.98	2.53	2.79	1.65	0.75	0.64
PB Ratio	2.93	2.53	3.12	1.60	-2.98	-2.06
P/TBV Ratio	13.07	17.21	78.88	-	-	-
P/FCF Ratio	-	-	-	-	13.52	17.47
P/OCF Ratio	-	28.90	470.51	19.27	7.21	8.42
EV/Sales Ratio	3.49	2.96	3.36	2.50	1.67	1.64
EV/EBITDA Ratio	19.16	17.28	19.44	19.70	12.35	9.88
EV/EBIT Ratio	38.26	29.91	34.11	24.01	14.66	11.97
EV/FCF Ratio	-	-	-	-	30.17	44.99
Debt / Equity Ratio	0.60	0.64	0.76	0.92	-3.76	-3.39
Debt / EBITDA Ratio	3.37	3.45	3.64	6.68	6.28	6.03
Debt / FCF Ratio	-	-	-	-	17.03	28.69
Asset Turnover	-	0.44	0.42	0.47	0.77	0.75
Inventory Turnover	-	1.52	1.93	2.18	2.70	2.96
Quick Ratio	-	0.56	0.66	0.70	0.35	0.67
Current Ratio	-	1.15	1.27	1.00	0.63	1.24
Return on Equity (ROE)	-	18.10%	4.74%	6.25%	-	-
Return on Assets (ROA)	-	2.73%	2.57%	3.04%	5.46%	6.46%
Return on Capital (ROIC)	-	4.04%	3.86%	4.84%	10.22%	11.93%
Return on Capital Employed (ROCE)	-	6.10%	6.00%	5.90%	38.60%	16.30%
Earnings Yield	1.99%	6.70%	1.40%	1.29%	5.82%	8.72%
FCF Yield	-	-3.73%	-2.82%	-50.06%	7.40%	5.72%
Dividend Yield	2.08%	2.58%	-	-	-	-
Buyback Yield / Dilution	-	-0.17%	-681.40%	-26.42%	-	-
Total Shareholder Return	2.08%	2.40%	-681.40%	-26.42%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.